Impact of Existing and Emerging Global US Melanoma Market Trends And Forecast 2020-2027

 Melanoma is a type of cancer that develops from pigment containing cells known as melanocytes. It is the most dangerous type of skin cancer. Sometimes they develop from moles showing significant change in color, increase in size, itchiness, irregular edges, changein color or skin breakdown. Exposure to ultra violet light in people with low pigment levels. The tumor can be either malignant or benign. Types of melanoma are superficial spreading melanoma, nodular melanoma, lentigo maglina melanoma, acral lentigious melanoma and others. About 98% of melanoma is localized in the US. Skin cancer are most common cancers in the US. Treatment available for melanoma include biologic therapy, immune therapy, radiation therapy, chemotherapy and surgery. Ultra violet exposure is known as risk factor of melanoma. Superficial spreading melanoma is the type of melanoma affecting large number of people in the US. The disease is more common in men than women.

The US melanoma market is expected to reach US$ 3.2 billion in 2023 from US$ 2.4 billion in 2016 with a CAGR of approximately 8.3%.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2950 

Segments:

US melanoma market has been segmented on the basis of type (superficial spreading, nodular, lentigo maglina, acral lentigious and others), by gender (male and female), by treatment (immunotherapy, biologic therapy, radiation therapy, chemotherapy, surgery and others), by diagnosis (ABCDE, ugly duckling, biopsy, and others) and by end users (hospitals, pharmaceutical companies, research centers, clinics, laboratories).

Regional Analysis of Melanoma Market:

Melanoma market in the US is divided into states comprising of Georgia, New Jersey, North Carolina, New York, Florida, Illinois, Ohio, Pennsylvania, Texas, Washington, California and, Virginia and Rest of US. California accounts for the largest market for melanoma in US followed by Florida and Ohio. California and Florida are key regions for melanoma market. Large number of melanoma cases are found in this region.  New York is the third largest market after Florida. According to American Society of Dermatology, prevalence of melanoma is gradually increasing.  and this spreads across the body. Number of skin cancer patients is growing steadily in Florida and Texas. This is due to their exposure to ultraviolet rays and extensive use of tanning beds in these regions. Technological advancement in the field of treatment and diagnosis of melanoma in the US also drives this market. The Food and Drug Administration (FDA) classifies tanning beds as "moderate risk" devices.

Key Players for Melanoma Market:

Some of the Key Players in this market are: Amgen, Inc., Bristol-Myers Squibb, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Genentech Inc. Janssen Biotech, Inc., and Novartis International AG. Pfizer, Vical and Ziopharm.

The report for US melanoma market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/us-melanoma-market-2950 

Throat Lozenges Market to Witness Widespread Expansion During 2020-2027

 According to MRFR,   the global throat lozenges market is expected to witness a moderate CAGR of 4.20% and generate a market value of USD 6.58 Billion by the end of 2023.

COVID-19 Analysis

A positive effect of the COVID-19 pandemic is expected on the Global Throat Lozenges Market. The typical signs of COVID-19 are a sore throat and coughing. Therefore, people under home confinement have been using at-home remedies for COVID-19 such as throat lozenges for chronic cough and over-the-counter pain relief for body aches. Therefore, in the next 2 to 3 years, the growing demand for throat lozenges for the treatment of initial COVID-19 symptoms of coughing and throat pain is expected to fuel the growth of the market for throat lozenges. The growing demand for throat lozenges has also led to the production of throat lozenges by companies from different industries. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1212 

Throat infections are common, and lozenges are usually the first line of defence for such conditions. Throat lozenges brands continue to leverage marketing tools to increase the commercial visibility of their product.  Other factors that are linked with the growth of global throat lozenges market include the development of new ingredients, rapid product penetration in fast-developing countries and low-price of throat lozenges. However, the availability of alternative treatments and therapies somewhat inhibit the market opportunities for throat lozenges.

Global Throat Lozenges Market: Segmental Analysis

MRFR’s report include a descriptive segmental analysis of the market based on type, ingredient, and indication. By type, the market has been segmented into hard-candy lozenges, soft lozenges, and compressed lozenges.  The hard-candy segment is further sub-segmented into chewy or caramel based medicated tablets and centre filled hard-candy lozenges. The hard candy lozenges segment currently accounts for more than one-third share of the market and is expected to remain highly lucrative during the forecast period. In 2017, over USD 2400 Mn worth hard-candy lozenges were sold globally. By ingredient, the market has been segmented into menthol, eucalyptus oil, mint, peppermint oil, honey & ginger, lemon, and others. Among these, the menthol segment accounts for the largest market share. In 2017, the segment reached a market valuation in excess of USD 1700 Mn and projected to expand at a CAGR of 3.45% by 2023. By indication, the market has been segmented into cold and cough, sore throat, throat diseases, and others. The sore throat segment holds the pole position and the trend is likely to continue over 2023. The segment surpassed a market valuation of USD 2400 Mn in 2017.

Global Throat Lozenges Market: Regional Analysis  

The report also includes a regional analysis of the market that covers Europe, North America, Asia Pacific (APAC), South America and the Middle East & Africa (MEA). Currently, North America and South America collectively account for the largest market share. In 2017, the Americas accounted for more that 31% share of the market.  North America in particular is expected to remain an important market for throat lozenges during the review period. Sales of OTC medial products including throat lozenges will continue to grow in the region in the years to come. Meanwhile, Europe has emerged as the single largest market for throat lozenges. Prevalence of common cold is considerably high in various parts of Europe, which acts as favorable element for the region’s throat lozenges market.

Global Throat Lozenges Market: Competitive Landscape

Bausch Health Companies Inc, Procter & Gamble, Prestige Brands Inc, Wrigley Company, Reckitt Benkiser Group plc, Gepach International, Bliss GVS Pharma Ltd, Thornton & Ross, Ricola AG, Ernest Jackson, Mondelēz International group, GlaxoSmithKline, Pfizer Inc., Doestsch Grether AG are some of the leading companies profiled in MRFR’s report.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/throat-lozenges-market-1212 

Hidradenitis Suppurativa Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

 Hidradenitis suppurativa is a rare, inflammatory skin condition that begins as small and painful pimples on the skin. This medical condition is most common between the ages of 20-40 years. Prevalence of hidradenitis suppurativa is three times more common in females than in males.

Increasing cases of various skin diseases are key driver for the global hidradenitis suppurativa market. FDA (U.S. Food and Drug Administration) approvals for drugs and clinical trials are major factor for the growth of the market. Over the past few years, due to increasing knowledge of the disease, and introduction of new drugs and treatment options, the market is continuously growing.

The Global hidradenitis suppurativa market is growing at the CAGR of ~4.2% during the forecast period and expected to reach USD 763.6 million by 2023.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/3770 

Increasing cases of various inflammatory skin diseases that may lead to Hidradenitis Suppurativa is a primary driving force expanding the market size its treatments. Simultaneously, FDA approvals for drugs and clinical trials are another major factor supporting the growth of the market.

The well-spread awareness about this disease and the availability of its treatments alongside the emergence of new drugs and treatment options is fostering the market growth over the past few years. Also, the environmental changes such as depletion of ozone layers and pollution are predominantly fuelling the market growth, increasing the occurrences of Hidradenitis Suppurativa.

On the flip side, factors like unmet medical needs & drug resistance along with the treatment cost obstruct the market growth. However, technological advancements took place in the medical science due to the substantial investments transpired in the R&D activities propel the market growth of the disease, bringing about the innovation & development of the medical devices, treatments & medicines.

Additionally, increasing population and growing urbanization along with the improving economic conditions that are enabling access to the quality and improved healthcare are expected to provide impetus to the growth of the Hidradenitis Suppurativa market.

Hidradenitis Suppurativa Market - Segmentations

MRFR has segmented its analysis into four key dynamics for enhanced understanding.

By Skin Conditions : Pimples, Folliculitis (Bacterial Folliculitis, Hot Tub Folliculitis (Pseudomonas Folliculitis), Barber's Itch (Pseudofolliculitis Barbae), Pityrosporum Folliculitis, and others), Deep-Acne (Cysts and Blackheads), and Boils (Furuncle Or Carbuncle, Cystic Acne, Pilondial Cyst, and others.), among others.

By Treatments       : Medications (Antibiotics, Antiandrogens, Immunosuppressive Drugs, Hormones, Pain Medication, Zinc Supplements, Sulphones, Retinoids, and others.), Surgery (Punch debridement, Incision and drainage, surgical removal, issue-sparing excision with electro-surgery, and others.), Laser Treatment, and Photodynamic Therapy (PDT), among others.

By End-users                       : Hospitals, Dermatology Clinics, Medical Research Centers, and Academic Institutes, among others.

By Regions              :  Europe, North America, APAC, and the Rest-of –the-World.

Global Hidradenitis Suppurativa Market - Regional Analysis

Globally, North America leads the global Hidradenitis Suppurativa market with the largest market share and is estimated to create a significant revenue pocket over the forecast period as well. Factors driving the market growth include a well-developed healthcare sector and the huge patient population suffering from various skin diseases and related medical complications. 

Besides, the changing lifestyle and increasing expenditures on cosmetics are some of the factors supporting the market growth.  The widened uptake of new technologies especially in the US is key driving factor acting as a tailwind to the market growth.

Expected to be the second-largest market for Hidradenitis Suppurativa, the Europe market is estimated to grow at a strong CAGR.  The resurging economy in the region is undoubtedly acting as a key force pushing up the growth of the regional market. 

Also, availability of funds for research, a vast patient population and increasing teenage population within the region are some of the key factors supporting the market growth in the region. West European countries like France, Germany, and the UK are accounting for significant contributors to the regional market, holding considerable market shares.

The Asia Pacific market for Hidradenitis Suppurativa is projected to emerge as a promising market, growing rapidly over the forecast period (2017 to 2023).  Markets in India and China backed by the vast population, and the availability of low-cost medications for the treatment are leading the regional market.

Furthermore, the increasing prevalence of Hidradenitis Suppurativa and rapidly increasing healthcare sector are some of the factors propelling the market growth in the region. Simultaneously, the vast unmet needs are expected to provide impetus to the market growth over the assessment period.

Whereas, due to the presence underdeveloped economies, lack of healthcare services and stringent government policies especially in the African region, the MEA market for Hidradenitis Suppurativa is estimated to observe a sluggish growth during the review period (2017 to 2023).  On the other hand, the GCC countries (Middle Eastern) such as UAE, Saudi Arabia, and Kuwait will boost the market growth with their well-developed healthcare sector and the colossal healthcare expenditure.

Global Hidradenitis Suppurativa Market   - Competitive Analysis

The global market for Hidradenitis Suppurativa appears intensely competitive with the several large and small players forming a competitive edge in the market incorporating strategic partnership, collaboration, acquisition, expansion, and technology launch.  Significant investments are transpired in clinical trials and the development of effective drugs.

Key Players:

Allergan (Republic of Ireland), AbbVie Inc. (US), AstraZeneca (UK), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc. (UK), Merck & Co., Inc. (US), and Pfizer Inc.(US)  are some of the leaders in the global Hidradenitis Suppurativa market. 

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hidradenitis-suppurativa-market-3770 

Global Electrotherapy Market 2020 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast By 2027

 Electrotherapy is a therapy which uses electrical impulses for soft tissue injuries, stimulate muscles and improve muscle strength and sensation. There are different use of electrotherapy such as pain management, cardiology, tissue repair, urine and fecal incontinence. Increasing use of electrotherapy by physiotherapist and sports person is driving the growth for the market. Technological advancement and innovation are some other major driving factors which supports the market growth. Some electrotherapy devices are also useful for weight loss. Increasing funding for new product development and rise in the new product launches is creating better competitive environment and also boosting the market for electrotherapy. 

The Global Electrotherapy market is growing at the CAGR of ~4.2% during the forecast period and expected to reach US$ 1119.1 million by 2023.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/3185 

The upsurge in the number of cases related to soft tissue injuries and muscles impairments are increasing the demand for electrotherapy devices. The electrotherapy market is expected to gain substantial traction due to the increased inclination of customers towards drug-free methods of treatment. Furthermore, the awareness of the benefits of electrotherapy is anticipated to provide more avenues for growth in the upcoming forecast period.

Segmental Analysis

The electrotherapy market has been segmented on the basis of type, devices, application, and region. On the basis of type, the market is segmented into Interferential, Extracorporeal Shock Wave Therapy, Magnetic Field Therapy (Pulsed Electro-Magnetic Field Energy, Constant Energy Magnets), Transcutaneous Electrical Nerve Stimulation (TENS) Therapy (Intense TENS, Conventional TENS, Acupuncture-like TENS (AL-TENS)), Ultrasound Therapy, and others. The segmentation on the basis of devices comprises of Electronic Muscle Stimulator (EMS), High Voltage Pulsed Galvanic Stimulator (HVPGS), Transcutaneous Electrical Neural Stimulator (TENS), Interferential Stimulator (IF), Microcurrent Stimulator (MC) or Microcurrent Electrical Neuromuscular Stimulator (MENS), among others. The segmentation of the electrotherapy market on application basis comprises of orthopedics, cardiology, urology, pain management (chronic fatigue, chronic pain, migraine headaches, diabetic nerve pain, wound healing, stimulating bone growth), Chronic and Acute Edema among others. The regions covered in the market are Europe, North America, Asia Pacific, Africa, and the Middle East.

Detailed Regional Analysis 

The regional analysis of the electrotherapy market comprises of regions such as North America, Europe, Asia Pacific, Africa, and the Middle East. The North American region is the major market for electrotherapy. In the North America region, the US controls a major market share while the European market is the next major region in the market. The growth rate is relatively higher in west European countries. Conversely, the Asia Pacific region is a rapidly growing market and is anticipated to control the market by the year 2023. The Middle East and African region are expected to have restrained growth in the market owing to a low-level awareness of the devices and treatment. 

Competitive Analysis

The plan formulation process in the market has become significantly easier in which deviations are well accounted for; this approach increases the overall success of these plans in the market. The leadership trends in the market are reinforcing the level of growth that can be achieved in the present market scenario. The alterations seen in terms of strategy execution and creation are altering the development pace of the market. The evolution patterns are revised in tandem to the customer likings to realize the greatest growth, and in the long run, viability. The framework for growth plans also has stimulated the market for potential new entrants. The market contenders are making considerable adjustments to minimize the incidence of competitive disadvantage. The market is also well equipped to meet the challenges and keep up with the dynamic growth trends effectively. The noteworthy competitors in the electrotherapy market are Eme srl (Italy), BTL (Czech Republic), EMS Physio Ltd. (UK), Medtronic (Republic of Ireland), Enraf-Nonius B.V.(Netherlands), Pure Care (US), gbo Medizintechnik AG (Germany), Phoenix Healthcare (UK), Omron Healthcare, Inc. (US), Walgreen Co. (US), STYMCO Technologies, LLC (US) and others

Industry Updates:

Jan 2018 Omron lately introduced its first wireless at-home drug-free pain management device, Avail, which is an FDA-cleared TENS device designed to provide symptomatic relief and management of acute and chronic pain. Avail is fully wireless and uses two contoured pads that permits users to treat multiple pain sites simultaneously.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/electrotherapy-market-3185 

Patient monitoring devices Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Market Scenario:

Patient monitoring devices in this report refer to the sensors which are used in smart wearable devices. Global Patient monitoring devices market is driven by increasing demand of wearable for infants and continuously evolving sensor technology. With increasing personal care and health consciousness, for tracking biometrics such as calories burnt, heart rate and others, the demand for wearable fitness trackers and other wearable is increasing. Rapid expansion of internet of things (IoT) is driving demand of Patient monitoring devices in various application areas such as healthcare and fitness, consumer electronics and others.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2484 

Market Highlights

The global Patient monitoring devices market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. These monitoring devices continuously check patient’s vital signs by using a medical monitor. Patient monitoring devices market has various functions such as glucose monitoring, blood monitoring, temperature monitoring, cholesterol monitoring, weight monitoring etc. Electrocardiography is fastest growing sub-segment, it is largest in cardiac monitoring market and fastest growing in neurological device. Electrocardiography is the process that checks for problems with the electrical activity of your heart. Electrocardiography is very helpful to diagnose unexplained chest pain or pressure, cause of symptoms of heart disease, to check how well medicines are working and see if they are causing side effects that affect the heart. Increase in consumer awareness is driving the market growth which expected to grow in same pace in near future. Patient monitoring devices manufacturers trying to make more advance, accurate and innovative device to provide desirable solution.

Global Patient monitoring devices market is segment into two major segments and its sub-segments such as based on type, based on product type and based on end user. Global Patient monitoring devices market is expected to reach USD 23.4 billion by 2022 at a CAGR of 5.7%. North America is the largest market for patient monitoring devices while Asia-Pacific region is fastest growing. Europe is second largest market for patient monitoring device and expected to grow steadily during forecasting period.

Global Patient monitoring devices Market Players:

There are plenty of large and small market players which operate in this market all over the globe. GE Healthcare, Roche Diagnostics, BIOTRONIK SE & Co. KG, Abbott Laboratories, Siemens Healthcare, Philips Healthcare, CAS Medical Systems, Inc., Spacelabs Healthcare, Honeywell International, Inc., Shenzhen Mindray Bio-Medical Electronics Co.

Regional Analysis:

Depending on geographic region, Patient monitoring devices market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, North America comprise largest market share in global Patient monitoring devices market. Moreover, the European market is also growing continuously. On the other hand, Asia-Pacific market is expected to grow at the fastest pace and rapidly in the Patient monitoring devices Market segment during the forecasted period. Middle East & Africa region are likely to have a limited but steady growth in the market.

Segmentation:

Patient monitoring devices Market has been segmented on the basis of product type which comprises of Central monitoring stations, Portable bedside monitors, Electrocardiogram (ECG) Devices, Hemodynamic Monitoring Devices, Fetal and neonatal monitors, Respiratory Monitors, Weight management monitors, Temperature monitoring devices, and others. On the basis of end user, the market is segmented into Hospitals and clinics, Ambulatory care centers, Home care and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/patient-monitoring-devices-market-2484 

Soaring Demand Drives Global Orthopedic Trauma Devices Market Growth During the Forecast Period, 2020-2027

 The global orthopedic trauma devices market is expected to register an approximate CAGR of 8% during the forecast period. Devices used to treat traumatic orthopedic injuries are termed as orthopedic trauma devices. The most common orthopedic injuries are distal radius fracture, stress fractures, rotator cuff tear, shoulder dislocation/labral tear, meniscus tear, anterior cruciate ligament (ACL) tear, and others. The increase in a number of accidents and severe fracture incidences are key factors for the market growth. According to the Association for Safe International Road Travel (ASIRT) approximately, 3,287 people die every day due to road accidents and 20 to 50 million are injured. It also mentioned that if actions are not taken, road accidents can be among the top five causes of death by 2030. Such high incidences of road accidents drive the market growth. Furthermore, technological advancements, increase in adoption of minimally invasive surgical procedures, increased prevalence of osteoarthritis, and orthopedic sports injury are also expected to drive the growth of the orthopedic trauma devices market.

However, factors such as high cost of orthopedic surgeries and the prevalence of product recalls are expected to hinder the market growth during the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2080 

Market Segmentation

The global orthopedic trauma device market is segmented on the basis of material type, product type and end-users.

The material types in the market are bio-absorbable materials, non-absorbable materials and others. The applications of bio-absorbable implants in orthopedic surgery are primarily mandated from the need to eliminate implant removal operations, thus gaining widespread popularity among orthopedic surgeons. Consistent development and product enhancement have given significant push to the bio-absorbable materials segment in the global market.

The product types in the global market are screws, plates, patient specific implants and others. The market for screws is expected to retain a massive share of the market due to favorable reimbursement policies and its wide array of applications in orthopedic surgeries. Moreover, benefits of orthopedic screws make them highly favorable, such as non-interference with MRI, decreased incidence of graft laceration and do not need implant removal. The end-users in the global market include hospitals, rehabilitation centers, clinics and others.

Regional Analysis

Globally, North America currently occupies the largest market for global orthopedic trauma devices market and is bound to secure its top position in the global market throughout the forecast period. Soaring use of bio-absorbable plates and screws is mainly fuelling the orthopedic trauma devices market in the region. Also, the region is witnessing robust sales of hybrid plates and screws, which will work in favor of the market growth in coming years. On top of that, intramedullary nails are steadily gaining traction in the majority of orthopedic surgeries owing to their increasing popularity as an ideal orthopedic trauma device for various anatomies, in the region.

Closely following the North America region stands the region of Europe, securing the second position in the global orthopedic trauma devices market. Trending incorporation of robotics technology during orthopedic surgeries is presumed to push the market in the region. The market also thrives on the back of constantly flourishing medical industry with well-established healthcare infrastructure.

According to the report, the Asia Pacific region is projected to be the fastest growing market. On the backdrop of an expanding market in developing nations in the region, flourishing medical tourism will continue to trigger the market for orthopedic trauma devices. Moreover, growing preference for minimally invasive fixation is expected to provide a tremendous thrust to the regional market as well. Growing geriatric population and increasing number of cases of injuries and road accidents also help the market captivate the region to a large extent.

The Middle East and Africa markets are exhibiting a positive outlook in terms of market expansion. This can be attributed to manufacturers consistently investing in research and development (R&D) activities to develop innovative and efficient devices, to cater to the growing demand. Large number of R&D activities is presumed to ensure enhanced growth opportunities during the forecast period. Moreover, increasing awareness regarding availability of innovative products among patients is pushing the market to higher levels in the region.

Key Players

Some of the key players in this market are: Invibio (UK), BIOTEK (India), DePuy Synthes Companies, Ortho Max Manufacturing Company Pvt. Ltd., Auxein Medical (India), Stryker, Johnson & Johnson Services, Inc. (US), Smith & Nephew, MEDTRONIC, B. Braun Melsungen AG and others.

Industry Developments

In June 2018, CoreLink acquired Expanding Orthopedics, a privately held medical device developer. The acquisition provides CoreLink with many benefits including growth in the inter-body product category along with growth in the portfolio of innovative orthopedic technology for advanced spine care. The acquisition will also boost the appeal of CoreLink’s recently launched FLXfit and FLXfit 15 titanium interbody systems.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/orthopedic-trauma-devices-market-2080 

mHealth Market: Information, Figures and Analytical Insights 2020-2027

 The global mHealth market is one of the fastest growing industries, owing to the changing dynamics of the legal and regulatory workflow and the intense competitive rivalry among large number of public companies. Mobile health (mHealth) is also one of the most modernized trends in the healthcare industry that has shown tremendous progress in the last few years. This trend is observed due to the increasing growth of personal health devices, which can be easily worn or used with a smartphone or tablet. The various factors that influence the growth of mHealth market are patient’s involvement in personal healthcare, implementation of smartphones and wearable devices into healthcare industry, integration of wireless technologies with healthcare devices that are portable, benefits of Cost effectiveness and patients’ convenience and Increase in lifestyle diseases. Globally the market for mHealth is expected to grow at 36.5% CAGR (2016-2022).

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1816 

The factors constraining the market are low mobile and network coverage in developing and poorer regions of the world, lower accuracy, poor penetration of smart devices, nascent technology in underdeveloped economies, limited reimbursement, lack of technological awareness among the ageing population, concerns over information security and privacy and others.

A careful analysis of the factors reveals the following;

• Poor network coverage and quality represent the most critical factor restraining the market
• Technological development in the mobile device and information management systems represent the critical opportunity factor for the market
• Growing mobile device affordability and awareness are the critical driving factors behind the market growth. According to Pew research, 78% of adults under 30 own a laptop or desktop computer, compared with 88% in 2010. Smartphone ownership, is very high at 86% of in 2015 in the age group of 18- to 29-year-olds.

The global mHealth market is projected to reach USD 21.71 billion by 2022, growing at a CAGR of 35.65% during the forecast period.

mHealth Market is segmented by devices, services, technology and applications. The device segment is sub segmented into blood glucose meters, BP monitors, pulse oximetry, neurological monitoring, wearable fitness sensor device, heart rate meters and others. The services segment is sub segmented into diagnosis, monitoring, prevention, treatment, and others. The application segment is sub segmented into cardiovascular, respiratory, neurological, genetic diseases and others.

The largest players in the mHealth market are Apple, AT&T, AirStrip, Boston Scientific, CardioNet, Athena health, Sanofi, Fitbit, Telcare, Zephyr Technology and others

Regional outlook

While mHealth grew out of industrialized nations, the field has shifted in favour of the developing countries, stemming from the rapid rise of mobile phone penetration in low-income nations. For example, in a study conducted by Pew research in contrast to a median of 45% across emerging and developing countries reported using the internet occasionally in 2013, the number in 2015, rose to a whopping 54%. The largest growth has been reported from large emerging economies such as Malaysia, Brazil and China. The comparative figures in 2015 was 87% for advanced economies such as U.S. and Canada, major Western European nations, Australia, Japan etc.

Another example can be seen in the falling divide for smartphone ownership between developing and developed economies. Smartphone ownership rates in emerging and developing nations climbed from a median of 21% in 2013 to an eye watering 37% in 2015. There also is an effect of the demographic dividend that is paying well for the market as in nearly every country, millennials are much more likely to be internet and smartphone users compared with those ages 35 and older. Other findings reveal that smartphone ownership rates have skyrocketed in many countries since 2013. This includes increases of over 25 percentage points among the economies of Turkey, Malaysia, Chile and Brazil.

In a number of emerging and developing countries, more people have access to the internet and are also using it more frequently. In 12 emerging nations surveyed in 2014 and 2015, there were significant increases in the share of adult internet users who say they access the internet several times a day, including in Nigeria (+20 points), Ghana (+19) and China (+13). Thus developing region nations are likely to be the leaders in mHealth market in the near future.

However Africa remains a dark continent for the mhealth market due to its poor socio economic conditions. The countries with the least smartphone ownership rates are Tanzania (11%), Uganda (4%) and Ethiopia (4%).

Social issues

Gender gaps and digital divide are raging issues that have been not analysed to the degree they demand. Men are more likely than women to use the internet and these differences are especially stark in African nations. Large gender gaps also appear on smartphone ownership with men being more likely to own a smartphone in many countries, in developing regions. The applications of mHealth also reflect the social reality. mHealth is restricted to dissemination of information, whereas the developed world is moving towards connected healthcare and big data applications.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mobile-health-market-1816